|
US5843937A
(en)
*
|
1996-05-23 |
1998-12-01 |
Panorama Research, Inc. |
DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
|
|
ATE310725T1
(de)
*
|
1996-09-12 |
2005-12-15 |
Auckland Uniservices Ltd |
Kondensierte n-acylindole als antitumormittel
|
|
US6130237A
(en)
*
|
1996-09-12 |
2000-10-10 |
Cancer Research Campaign Technology Limited |
Condensed N-aclyindoles as antitumor agents
|
|
JP4862120B2
(ja)
*
|
2001-02-22 |
2012-01-25 |
ユニヴァーシティ オブ ブラッドフォード |
腫瘍治療のためのプロドラッグとしてのベンズ−インドールおよびベンゾ−キノリン誘導体
|
|
DE10121217A1
(de)
*
|
2001-04-30 |
2002-10-31 |
Merck Patent Gmbh |
6H-Oxazolo[4,5-e]indol-Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden
|
|
DE10121215A1
(de)
*
|
2001-04-30 |
2002-10-31 |
Merck Patent Gmbh |
Dihydro-imidazo[4,5-e]indol- und 7H-Pyrrolo[3,2-f]chinoxalin Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden
|
|
DK1392359T4
(da)
|
2001-05-11 |
2013-06-10 |
Ludwig Inst For Cancer Res Ltd |
Specifikke bindingsproteiner og deres anvendelser.
|
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
|
KR20030033007A
(ko)
*
|
2001-05-31 |
2003-04-26 |
코울터 파머수티컬, 인코포레이티드 |
세포독소, 약물전구체, 링커 및 이에 유용한 안정화제
|
|
WO2003022274A2
(en)
*
|
2001-09-13 |
2003-03-20 |
Synta Pharmaceuticals Corp. |
2-aroylimidazole compounds for treating cancer
|
|
US6756397B2
(en)
*
|
2002-04-05 |
2004-06-29 |
Immunogen, Inc. |
Prodrugs of CC-1065 analogs
|
|
BRPI0510909A2
(pt)
*
|
2004-05-19 |
2008-12-16 |
Medarex Inc |
composto de ligaÇço fÁrmaco-ligante citotàxico, formulaÇço farmacÊutica, mÉtodo para matar uma cÉlula e mÉtodo para retardar ou interromper o crescimento de tumor
|
|
US7691962B2
(en)
*
|
2004-05-19 |
2010-04-06 |
Medarex, Inc. |
Chemical linkers and conjugates thereof
|
|
US7393665B2
(en)
*
|
2005-02-10 |
2008-07-01 |
Population Genetics Technologies Ltd |
Methods and compositions for tagging and identifying polynucleotides
|
|
ES2386366T3
(es)
*
|
2005-02-18 |
2012-08-17 |
Medarex, Inc. |
Anticuerpo monoclonal humano contra el antígeno de membrana específico de la próstata (PSMA)
|
|
US7714016B2
(en)
*
|
2005-04-08 |
2010-05-11 |
Medarex, Inc. |
Cytotoxic compounds and conjugates with cleavable substrates
|
|
EA016577B1
(ru)
*
|
2005-09-26 |
2012-06-29 |
Медарекс, Инк. |
Конъюгаты антитело-лекарство и их применение
|
|
EP1934261B1
(en)
|
2005-09-26 |
2014-10-29 |
Medarex, L.L.C. |
Human monoclonal antibodies to cd70
|
|
BRPI0619331A2
(pt)
*
|
2005-10-26 |
2011-09-27 |
Medarex Inc |
método para fazer um composto para preparar um análogo de cbi cc-1065, método para preparar um análogo de cbi cc-1065 e composto
|
|
WO2007059404A2
(en)
|
2005-11-10 |
2007-05-24 |
Medarex, Inc. |
Duocarmycin derivatives as novel cytotoxic compounds and conjugates
|
|
NZ569236A
(en)
|
2005-12-08 |
2012-06-29 |
Medarex Inc |
Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and their use
|
|
EA017491B1
(ru)
|
2005-12-08 |
2012-12-28 |
Медарекс, Инк. |
Человеческие моноклональные антитела к фукозил-gm1 и способы применения антифукозил-gm1 антител
|
|
US20090175886A1
(en)
|
2006-01-17 |
2009-07-09 |
Medarex, Inc. |
Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
|
|
CN101627055A
(zh)
|
2006-09-05 |
2010-01-13 |
梅达雷克斯公司 |
骨形成蛋白及其受体的抗体以及它们的使用方法
|
|
SG177168A1
(en)
|
2006-12-01 |
2012-01-30 |
Medarex Inc |
Human antibodies that bind cd22 and uses thereof
|
|
CL2007003622A1
(es)
|
2006-12-13 |
2009-08-07 |
Medarex Inc |
Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
|
|
US20100150950A1
(en)
|
2006-12-14 |
2010-06-17 |
Medarex, Inc. |
Human antibodies that bind cd70 and uses thereof
|
|
TWI412367B
(zh)
|
2006-12-28 |
2013-10-21 |
梅達雷克斯有限責任公司 |
化學鏈接劑與可裂解基質以及其之綴合物
|
|
US9090693B2
(en)
|
2007-01-25 |
2015-07-28 |
Dana-Farber Cancer Institute |
Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease
|
|
JP2010519310A
(ja)
|
2007-02-21 |
2010-06-03 |
メダレックス インコーポレイテッド |
単一のアミノ酸を有する化学リンカーおよびその複合体
|
|
JP5618549B2
(ja)
*
|
2007-03-15 |
2014-11-05 |
ルードヴィッヒ インスティテュート フォー キャンサーリサーチ リミテッド |
Ｅｇｆｒ抗体及びｓｒｃ阻害剤を用いる治療方法及び関連製剤
|
|
US9901567B2
(en)
|
2007-08-01 |
2018-02-27 |
Syntarga B.V. |
Substituted CC-1065 analogs and their conjugates
|
|
JP5532486B2
(ja)
|
2007-08-14 |
2014-06-25 |
ルードヴィッヒ インスティテュート フォー キャンサー リサーチ |
Ｅｇｆ受容体を標的とするモノクローナル抗体１７５ならびにその誘導体および用途
|
|
CA2723883C
(en)
*
|
2007-11-13 |
2014-10-28 |
The Scripps Research Institute |
Cbi derivatives subject to reductive activation
|
|
HUE035798T2
(en)
|
2008-11-03 |
2018-05-28 |
Syntarga Bv |
CC-1065 analogues and conjugates
|
|
JP5816558B2
(ja)
|
2009-03-05 |
2015-11-18 |
メダレックス・リミテッド・ライアビリティ・カンパニーＭｅｄａｒｅｘ， Ｌ．Ｌ．Ｃ． |
Ｃａｄｍ１に特異的な完全ヒト抗体
|
|
NZ616382A
(en)
|
2009-04-20 |
2015-04-24 |
Oxford Biotherapeutics Ltd |
Antibodies specific to cadherin-17
|
|
US20110076232A1
(en)
*
|
2009-09-29 |
2011-03-31 |
Ludwig Institute For Cancer Research |
Specific binding proteins and uses thereof
|
|
US20120231004A1
(en)
|
2009-10-13 |
2012-09-13 |
Oxford Biotherapeutic Ltd. |
Antibodies
|
|
DE102009051438A1
(de)
|
2009-10-30 |
2011-05-05 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts |
Fluoreszenzfarbstoffe
|
|
NO3056203T3
(enExample)
|
2010-04-21 |
2018-05-12 |
|
|
|
EP2717916B1
(en)
|
2011-06-10 |
2017-03-08 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
EA031181B1
(ru)
|
2011-06-28 |
2018-11-30 |
Оксфорд Байотерепьютикс Лтд. |
Антитело, которое специфически связывается с bst1, или его антигенсвязывающий фрагмент, нуклеиновые кислоты, кодирующие его цепи, клетка-хозяин, способ получения этого антитела и применение для лечения рака и воспалительных заболеваний
|
|
US10131682B2
(en)
|
2012-11-24 |
2018-11-20 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
|
|
WO2014093394A1
(en)
|
2012-12-10 |
2014-06-19 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
US9872918B2
(en)
|
2012-12-12 |
2018-01-23 |
Mersana Therapeutics, Inc. |
Hydroxyl-polymer-drug-protein conjugates
|
|
KR20210132742A
(ko)
|
2012-12-21 |
2021-11-04 |
알트루바이오 인코퍼레이티드 |
친수성 자기-희생 링커 및 그것의 포합체
|
|
TR201904426T4
(tr)
|
2013-03-28 |
2019-04-22 |
Scripps Research Inst |
Siklik n-asil o-amino fenol cbı türevi.
|
|
WO2015050959A1
(en)
|
2013-10-01 |
2015-04-09 |
Yale University |
Anti-kit antibodies and methods of use thereof
|
|
CA2927022C
(en)
|
2013-10-11 |
2018-08-21 |
Asana Biosciences, Llc |
Protein-polymer-drug conjugates
|
|
WO2015054659A1
(en)
|
2013-10-11 |
2015-04-16 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
TR201810856T4
(tr)
|
2014-01-10 |
2018-08-27 |
Synthon Biopharmaceuticals Bv |
CYS'le bağlı antikor-ilaç konjugatlarını saflaştırmak için usul.
|
|
JP6417421B2
(ja)
|
2014-02-28 |
2018-11-07 |
ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． |
荷電連結体及び共役体のためのその使用
|
|
SG11201607818WA
(en)
|
2014-03-20 |
2016-10-28 |
Bristol Myers Squibb Co |
Stabilized fibronectin based scaffold molecules
|
|
KR20170020868A
(ko)
|
2014-06-20 |
2017-02-24 |
바이오얼라이언스 씨.브이. |
항-폴레이트 수용체 알파 (fra) 항체-약물 컨쥬게이트 및 그것의 사용 방법
|
|
ES2826566T3
(es)
|
2014-11-21 |
2021-05-18 |
Bristol Myers Squibb Co |
Anticuerpos que comprenden regiones constantes pesadas modificadas
|
|
JP6805142B2
(ja)
|
2014-11-21 |
2020-12-23 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ｃｄ７３に対する抗体およびその使用
|
|
JP6622814B2
(ja)
|
2014-11-25 |
2019-12-18 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
イメージングのための新規ｐｄ−ｌ１結合ポリペプチド
|
|
ES2736106T3
(es)
|
2015-03-10 |
2019-12-26 |
Bristol Myers Squibb Co |
Anticuerpos que se pueden conjugar mediante la transglutaminasa y conjugados producidos a partir de ellos
|
|
AU2016271111B2
(en)
|
2015-05-29 |
2022-04-28 |
Bristol-Myers Squibb Company |
Antibodies against OX40 and uses thereof
|
|
CA2991973C
(en)
|
2015-07-12 |
2021-12-07 |
Suzhou M-Conj Biotech Co., Ltd. |
Bridge linkers for conjugation of a cell-binding molecule
|
|
US9839687B2
(en)
|
2015-07-15 |
2017-12-12 |
Suzhou M-Conj Biotech Co., Ltd. |
Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
|
|
CN104961645A
(zh)
*
|
2015-07-22 |
2015-10-07 |
中国药科大学 |
苯氧乙酸类衍生物、其制备方法及其作为药物的用途
|
|
EP3394096A1
(en)
|
2015-12-21 |
2018-10-31 |
Bristol-Myers Squibb Company |
Variant antibodies for site-specific conjugation
|
|
WO2017120534A1
(en)
|
2016-01-08 |
2017-07-13 |
Bioalliance C.V. |
Tetravalent anti-psgl-1 antibodies and uses thereof
|
|
AU2017228470A1
(en)
|
2016-03-04 |
2018-08-30 |
Bristol-Myers Squibb Company |
Combination therapy with anti-CD73 antibodies
|
|
US11617799B2
(en)
|
2016-06-27 |
2023-04-04 |
Tagworks Pharmaceuticals B.V. |
Cleavable tetrazine used in bio-orthogonal drug activation
|
|
WO2018035391A1
(en)
|
2016-08-19 |
2018-02-22 |
Bristol-Myers Squibb Company |
Seco-cyclopropapyrroloindole compounds, antibody-drug conjugates thereof, and methods of making and use
|
|
US20190218294A1
(en)
|
2016-09-09 |
2019-07-18 |
Bristol-Myers Squibb Company |
Use of an anti-pd-1 antibody in combination with an anti-mesothelin antibody in cancer treatment
|
|
KR20220147719A
(ko)
|
2016-11-14 |
2022-11-03 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
|
|
US11135307B2
(en)
|
2016-11-23 |
2021-10-05 |
Mersana Therapeutics, Inc. |
Peptide-containing linkers for antibody-drug conjugates
|
|
MX2019013132A
(es)
|
2017-05-25 |
2020-01-27 |
Bristol Myers Squibb Co |
Anticuerpos que comprenden regiones constantes pesadas modificadas.
|
|
US10772971B2
(en)
|
2017-06-22 |
2020-09-15 |
Mersana Therpeutics, Inc. |
Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugates
|
|
AU2019262521B2
(en)
|
2018-05-04 |
2024-04-18 |
Tagworks Pharmaceuticals B.V. |
Compounds comprising a linker for increasing transcyclooctene stability
|
|
CA3099419A1
(en)
|
2018-05-04 |
2019-11-07 |
Tagworks Pharmaceuticals B.V. |
Tetrazines for high click conjugation yield in vivo and high click release yield
|
|
CA3117050A1
(en)
|
2018-10-29 |
2020-05-07 |
Mersana Therapeutics, Inc. |
Cysteine engineered antibody-drug conjugates with peptide-containing linkers
|
|
WO2020256546A1
(en)
|
2019-06-17 |
2020-12-24 |
Tagworks Pharmaceuticals B.V. |
Compounds for fast and efficient click release
|
|
IL289094A
(en)
|
2019-06-17 |
2022-02-01 |
Tagworks Pharmaceuticals B V |
Tetrazines for increasing the speed and yield of the "click release" reaction
|
|
EP4399283A2
(en)
|
2021-09-06 |
2024-07-17 |
Veraxa Biotech GmbH |
Novel aminoacyl-trna synthetase variants for genetic code expansion in eukaryotes
|
|
CN117980327A
(zh)
|
2021-11-03 |
2024-05-03 |
杭州多禧生物科技有限公司 |
抗体的特异性偶联
|
|
DK4186529T3
(da)
|
2021-11-25 |
2025-08-25 |
Veraxa Biotech Gmbh |
Forbedrede antistof-payload-konjugater (apc) fremstillet ved stedspecifik konjugering ved hjælp af genetisk kodeudvidelse
|
|
JP2024543916A
(ja)
|
2021-11-25 |
2024-11-26 |
ヴェラクサ バイオテック ゲーエムベーハー |
遺伝暗号拡張を利用した部位特異的結合によって調製された改良された抗体ペイロード複合体（ａｐｃ）
|
|
KR20240119102A
(ko)
|
2021-12-08 |
2024-08-06 |
유럽피안 몰레큘러 바이올로지 래보러토리 |
표적화 접합체의 제조를 위한 친수성 테트라진-관능화 페이로드
|
|
EP4372000B1
(en)
|
2022-02-15 |
2026-06-17 |
Tagworks Pharmaceuticals B.V. |
Masked il12 protein
|
|
KR20250049568A
(ko)
|
2022-07-15 |
2025-04-11 |
페온 테라퓨틱스 리미티드 |
Cdcp1에 결합하는 항체 약물 접합체 및 이의 용도
|
|
IL320221A
(en)
|
2022-10-12 |
2025-06-01 |
Tagworks Pharmaceuticals B V |
Strained bicyclo-nonanes
|
|
CN120569216A
(zh)
|
2023-01-20 |
2025-08-29 |
巴斯夫欧洲公司 |
稳定型生物聚合物组合物、其制造和用途
|
|
JP2026509291A
(ja)
|
2023-03-10 |
2026-03-17 |
タグワークス ファーマシューティカルス ビー．ブイ． |
向上されたｔ－リンカーを有するトランス－シクロオクテン
|
|
EP4750750A1
(en)
|
2023-07-27 |
2026-06-03 |
Veraxa Biotech GmbH |
Hydrophilic trans-cyclooctene (hytco) compounds, constructs and conjugates containing the same
|
|
CN122206462A
(zh)
|
2023-09-15 |
2026-06-12 |
巴斯夫欧洲公司 |
稳定型生物聚合物组合物、其制造和用途
|
|
WO2025149667A1
(en)
|
2024-01-12 |
2025-07-17 |
Pheon Therapeutics Ltd |
Antibody drug conjugates and uses thereof
|
|
WO2025174248A1
(en)
|
2024-02-16 |
2025-08-21 |
Tagworks Pharmaceuticals B.V. |
Trans-cyclooctenes with "or gate" release
|
|
TW202617187A
(zh)
|
2024-08-22 |
2026-05-01 |
荷蘭商泰格沃克斯製藥有限公司 |
反-環辛烯調配物
|
|
WO2026078060A1
(en)
|
2024-10-08 |
2026-04-16 |
Basf Se |
Tocopherol alkoxylates for biopolymer stabilization
|
|
WO2026139575A1
(en)
|
2024-12-23 |
2026-07-02 |
Veraxa Biotech Gmbh |
Novel tco-functionalized glycan engineered immunoglobulin molecules, novel tco-functionalized saccharide compounds for preparing the same, and novel antibody payload conjugates
|